The Patent Finder

Axovant Sciences GmbH

Also on record
Records under this name other than patents Axovant Sciences GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Axovant Sciences GmbH

PatentTitleStatus Expires Confidence
US 10,034,859Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Hallucinations Associated with a Neurodegenerative Disease
Lapsed on the fee record
Ended Jul 31, 2026 · High confidence
Lapsed on the fee recordEnded Jul 31, 2026High confidence
US 10,022,355Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder
Lapsed on the fee record
Ended Jul 17, 2026 · High confidence
Lapsed on the fee recordEnded Jul 17, 2026High confidence
US 11,304,932Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Hallucinations Associated with a Neurodegenerative Disease
Lapsed on the fee record
Ended Apr 19, 2026 · High confidence
Lapsed on the fee recordEnded Apr 19, 2026High confidence
US 7,452,888Quinoline Derivatives and Their Use as 5-HT6 Ligands
Term ended
Term ended Sep 21, 2024 · High confidence
Term endedTerm ended Sep 21, 2024High confidence
US 10,428,062Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
Lapsed on the fee record
Ended Oct 1, 2023 · High confidence
Lapsed on the fee recordEnded Oct 1, 2023High confidence
US 10,370,370Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
Lapsed on the fee record
Ended Aug 6, 2023 · High confidence
Lapsed on the fee recordEnded Aug 6, 2023High confidence
US 9,084,742Combinations Comprising 3-Phenylsulfonyl-8-Piperazinyl-1YL-QUINOLINE
Lapsed on the fee record
Ended Jul 21, 2023 · High confidence
Lapsed on the fee recordEnded Jul 21, 2023High confidence
US 7,977,337Quinoline Derivatives and Their Use as 5-HT6 Ligands
Term ended
Term ended Mar 25, 2023 · Medium confidence
Term endedTerm ended Mar 25, 2023Medium confidence
US 8,236,947Quinoline Derivatives and Their Use as 5-HT6 Ligands
Term ended
Term ended Mar 25, 2023 · Medium confidence
Term endedTerm ended Mar 25, 2023Medium confidence
US 10,183,938Geminal Substituted Quinuclidine Amide Compounds as Agonists of ALPHA-7 Nicotonic Acetylcholine Receptors
Lapsed on the fee record
Ended Jan 22, 2023 · High confidence
Lapsed on the fee recordEnded Jan 22, 2023High confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited